NRXP · NRX Pharmaceuticals, Inc. · Documents
$2.64
+0.02 (+0.76%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$113.43M
Shares
43.30M
Volume · Oct 21
386.39K
Avg daily vol (3M)
878.22K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | NRX Pharmaceuticals' board set December 17, 2026 for its virtual 2026 Annual Meeting of Stockholders at 10:00 a.m. Eastern, with an October 28, 2026 record date and an October 25, 2026 deadline for stockholder proposals and director nominations. | 2026-10-16 | — | |
| 8-K | — | 2026-10-05 | 2026-09-29 | |
| 8-K | — | 2026-09-16 | 2026-09-15 | |
| 8-K | — | 2026-09-14 | 2026-09-08 | |
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| 8-K | — | 2026-08-17 | — | |
| 10-Q | — | 2026-08-14 | 2026-06-30 | |
| 8-K | — | 2026-08-07 | — | |
| 8-K | — | 2026-07-22 | 2026-07-21 | |
| 8-K | — | 2026-06-04 | 2026-06-03 | |
| 8-K | — | 2026-06-02 | — | |
| Investor Event Transcript | — | 2026-05-18 | 2026-03-31 | |
| 10-Q | — | 2026-05-15 | 2026-03-31 | |
| 8-K | — | 2026-03-24 | 2026-03-23 | |
| Investor Event Transcript | — | 2026-03-24 | 2025-12-31 | |
| 10-K | — | 2026-03-23 | 2025-12-31 | |
| DEFA14A | — | 2026-02-24 | — | |
| DEF 14A | — | 2026-02-23 | 2026-03-23 | |
| ARS | — | 2026-02-23 | 2024-12-31 | |
| 8-K | — | 2026-02-17 | — | |
| 8-K | — | 2026-02-17 | — | |
| PRE 14A | — | 2026-02-13 | 2026-03-23 | |
| 8-K | — | 2026-02-02 | 2026-01-27 | |
| 8-K | — | 2026-01-16 | 2026-01-12 | |
| Investor Event Transcript | — | 2025-12-31 | — | |
| 8-K | — | 2025-12-29 | 2025-12-18 | |
| S-3/A | — | 2025-12-12 | — | |
| 8-K | — | 2025-11-26 | 2025-11-20 | |
| 8-K/A | — | 2025-11-21 | 2025-09-08 | |
| 10-Q | — | 2025-11-14 | 2025-09-30 | |
| 8-K | — | 2025-10-23 | 2025-10-17 | |
| 8-K | — | 2025-09-26 | 2025-09-24 | |
| 8-K | — | 2025-09-12 | 2025-09-08 | |
| 8-K | — | 2025-09-08 | 2025-09-02 | |
| 10-Q | — | 2025-08-18 | 2025-06-30 | |
| 8-K | — | 2025-08-18 | — | |
| 8-K | — | 2025-08-15 | 2025-08-11 | |
| NT 10-Q | — | 2025-08-14 | 2025-06-30 | |
| S-3 | — | 2025-06-20 | — | |
| 8-K | — | 2025-06-09 | 2025-06-05 | |
| 8-K | — | 2025-05-21 | 2025-05-15 | |
| 10-Q | — | 2025-05-15 | 2025-03-31 | |
| 8-K | — | 2025-05-13 | — | |
| 10-K/A | — | 2025-04-30 | 2024-12-31 | |
| 8-K | — | 2025-04-17 | — | |
| 8-K | — | 2025-03-21 | 2025-03-17 | |
| 10-K | — | 2025-03-14 | 2024-12-31 | |
| 8-K | — | 2025-02-03 | 2025-01-28 | |
| 8-K | — | 2025-01-29 | 2025-01-27 | |
| 8-K | — | 2025-01-22 | 2025-01-15 |
Showing 1–50 of 209 filings